Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Low-dose Ketamine Infusion Versus Usual Care for Sickle Cell Pain Crisis: a Randomized, Prospective Study.

NCT04005209 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04005209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Low-dose Ketamine Infusion Versus Usual Care for Sickle Cell Pain Crisis: a Randomized, Prospective Study.
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Withdrawn
Start date
January 31, 2022
Completion date
November 30, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain, anemia; sickle-cell, with crisis